Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Kral, A. H.
Right arrow Articles by Edlin, B. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kral, A. H.
Right arrow Articles by Edlin, B. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Am J Epidemiol 2003; 157:915-922.
Copyright © 2003 by Johns Hopkins Bloomberg School of Public Health


ORIGINAL CONTRIBUTIONS

Trends in Human Immunodeficiency Virus Seroincidence among Street-Recruited Injection Drug Users in San Francisco, 1987–1998

Alex H. Kral1,, Jennifer Lorvick1, Lauren Gee1, Peter Bacchetti2, Bhupat Rawal3, Michael Busch3 and Brian R. Edlin1

1 Urban Health Study, Department of Family and Community Medicine, University of California, San Francisco, San Francisco, CA.
2 Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.
3 Blood Centers of the Pacific, San Francisco, CA.

This paper reports trends in human immunodeficiency virus (HIV) incidence among street-recruited injection drug users (IDUs) in San Francisco, California, from 1987 through 1998, estimated using a sensitive/less sensitive enzyme immunoassay testing strategy. IDUs were enrolled in 23 semiannual cross-sections from three community sites. For identification of recent infections, less sensitive enzyme immunoassay testing was performed on stored specimens that had previously tested positive for HIV antibodies. Annualized incidence rates were calculated and logistic regression models were fitted for assessment of risk factors for recent HIV infection. Among 8,065 susceptible IDUs, 34 had recent infections, for an incidence rate of 1.2% (95% confidence interval: 0.7, 2.0) per person-year. This rate declined from 2.7% in 1987/1988 to approximately 1% per person-year between 1989 and 1998. Two IDU subpopulations were at highest risk for infection: persons under age 30 years (2.8% per person-year) and men who had sex with men (3.0% per person-year). Participants who reported prior HIV test-result counseling were less likely than others to become infected (adjusted odds ratio = 0.43, 95% confidence interval: 0.21, 0.87). Sensitive/less sensitive enzyme immunoassay testing is an effective tool for assessing HIV incidence. HIV incidence among street-recruited IDUs in San Francisco appears to have remained stable and moderate since the late 1980s.

adolescence; HIV; homosexuality, male; incidence; risk factors; sex behavior; substance abuse, intravenous

Abbreviations: Abbreviations: CI, confidence interval; EIA, enzyme immunoassay; HIV, human immunodeficiency virus; IDUs, injection drug users; OR, odds ratio.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
K. Page-Shafer, B. L. Pappalardo, L. H. Tobler, B. H. Phelps, B. R. Edlin, A. R. Moss, T. L. Wright, D. J. Wright, T. R. O'Brien, S. Caglioti, et al.
Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates
J. Clin. Microbiol., February 1, 2008; 46(2): 499 - 506.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Public HealthHome page
R. Heimer, L. E. Grau, E. Curtin, K. Khoshnood, and M. Singer
Assessment of HIV Testing of Urban Injection Drug Users: Implications for Expansion of HIV Testing and Prevention Efforts
Am J Public Health, January 1, 2007; 97(1): 110 - 116.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Public HealthHome page
D. C. Des Jarlais, T. Perlis, K. Arasteh, L. V. Torian, S. Beatrice, J. Milliken, D. Mildvan, S. Yancovitz, and S. R. Friedman
HIV Incidence Among Injection Drug Users in New York City, 1990 to 2002: Use of Serologic Test Algorithm to Assess Expansion of HIV Prevention Services
Am J Public Health, August 1, 2005; 95(8): 1439 - 1444.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Tsui, B. L. Herring, J. D. Barbour, R. M. Grant, P. Bacchetti, A. Kral, B. R. Edlin, and E. L. Delwart
Human Immunodeficiency Virus Type 1 Superinfection Was Not Detected following 215 Years of Injection Drug User Exposure
J. Virol., January 1, 2004; 78(1): 94 - 103.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.